Teva CEO on Shares Trading Directly on the NYSE

Richard Francis, president and CEO of Teva Pharmaceuticals, announced that Teva shares will trade directly on the New York Stock Exchange rather than as American Depositary Receipts. Francis discussed the timing of the transition and its effects on investor trading in an interview on Bloomberg's "The Close" with Romaine Bostick and Isabelle Lee.

Next story